<DOC>
	<DOC>NCT01914042</DOC>
	<brief_summary>Clinical, psychophysical, behavioral or genetic factor will predict the response to opioid treatment in patients with chronic neuropathic pain.</brief_summary>
	<brief_title>Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>1. Patients with moderate to severe chronic neuropathic pain or patients with radiculitis between 18 and 75 years of age. 2. Candidates for chronic opioid therapy for nonmalignant pain as determined by treating physician. 3. Patients treated with nonopioid analgetics, anti inflammatory drugs or low opioid dosage (&lt; 30 mg of oral morphineequivalents per day). 4. Ability to understand the purpose and instructions of the study and to sign an informed consent. 1.Diabetic Neuropathy 2.Pain in upper limbs 3.Receiving anti depressants and/or anticonvulsants 4.Pregnant women 5.Inability to comply with study protocol. 6.Allergy to Opioids 7.A diagnosis of Raynaud's Syndrome 8.History of substance abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Opioid induced hyperalgesia</keyword>
	<keyword>Neuropathic pain</keyword>
	<keyword>Opioids</keyword>
	<keyword>Sciatica</keyword>
	<keyword>Serotonin-norepinephrine reuptake inhibitor (SNRI)</keyword>
</DOC>